Synthebio

Our medical device eliminates excess fat, up to 5 cm. waist reduction after one painless 20-min session. Dr. Kleinsinger's previous co is listed on Nasdaq.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Paris, France
  • Currency EUR
  • Founded June 2008
  • Employees 3
  • Incorporation Type Other
  • Website synthebio.com

Company Summary

Synthebio has created with CNRS the Convergent Ultrasound technology that eliminates fat excess and developed the Slimiser medical device. The results are 2 x more efficient, the treatment is 10 times faster than competitors.
Synthebio is led by a team of seniors with complementary skills managed by Dr. Kleinsinger, former creator and CEO of Eyegate Pharmaceuticals, now listed on Nasdaq. The Slimiser is reaching the market (CE mark in progress).

Team

  • Alain Kleinsinger
    CEO

    DDS, serial entrepreneur. The previous company (medical device) he created and managed during 8 years is now listed on Nasdaq. He has won the innovation award (French Ministry of Research), has a Master in entrepreneurship and teaches in an MBA program.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free